Febuxostat

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Febuxostat and local guidelines before prescribing.

Xanthine oxidase inhibitor

Mechanism

Non-purine xanthine oxidase inhibitor.

Uses

Chronic gout when allopurinol unsuitable.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Gout flares at start, raised LFT, nausea, cardiovascular death signal.

Interactions

Azathioprine and mercaptopurine toxicity.

Contraindications and cautions

Ischaemic heart disease, heart failure

Monitoring

Urate, LFT

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Caution in severe renal or hepatic impairment

Overdose and reversal

Supportive

Special advice

Use colchicine or NSAID cover for the first months; avoid in established cardiovascular disease.

More from the textbook: uses, cautions and other points
Where it is discussed in the book